X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sun Pharma with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ALEMBIC LTD - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA ALEMBIC LTD SUN PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 32.5 54.8 59.3% View Chart
P/BV x 2.7 2.2 123.7% View Chart
Dividend Yield % 0.5 0.5 100.1%  

Financials

 SUN PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    SUN PHARMA
Mar-18
ALEMBIC LTD
Mar-18
SUN PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs70172 972.9%   
Low Rs43334 1,277.9%   
Sales per share (Unadj.) Rs110.44.7 2,348.8%  
Earnings per share (Unadj.) Rs11.06.1 179.9%  
Cash flow per share (Unadj.) Rs17.26.2 275.9%  
Dividends per share (Unadj.) Rs2.000.20 1,000.0%  
Dividend yield (eoy) %0.40.4 93.4%  
Book value per share (Unadj.) Rs158.840.7 390.5%  
Shares outstanding (eoy) m2,399.26267.03 898.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.111.3 45.6%   
Avg P/E ratio x51.68.7 595.2%  
P/CF ratio (eoy) x32.98.5 388.1%  
Price / Book Value ratio x3.61.3 274.1%  
Dividend payout %18.23.3 556.0%   
Avg Mkt Cap Rs m1,360,02114,139 9,618.8%   
No. of employees `00017.8NA-   
Total wages/salary Rs m53,671207 25,877.8%   
Avg. sales/employee Rs Th14,890.9NM-  
Avg. wages/employee Rs Th3,017.1NM-  
Avg. net profit/employee Rs Th1,480.6NM-  
INCOME DATA
Net Sales Rs m264,8951,255 21,103.8%  
Other income Rs m8,388370 2,265.7%   
Total revenues Rs m273,2821,625 16,813.2%   
Gross profit Rs m56,081111 50,478.2%  
Depreciation Rs m14,99838 39,678.3%   
Interest Rs m5,1762 304,452.9%   
Profit before tax Rs m44,295442 10,026.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m-9,5050-   
Tax Rs m8,45224 35,289.8%   
Profit after tax Rs m26,3381,630 1,616.0%  
Gross profit margin %21.28.9 239.2%  
Effective tax rate %19.15.4 352.0%   
Net profit margin %9.9129.8 7.7%  
BALANCE SHEET DATA
Current assets Rs m316,3591,867 16,943.9%   
Current liabilities Rs m198,643591 33,600.0%   
Net working cap to sales %44.4101.6 43.7%  
Current ratio x1.63.2 50.4%  
Inventory Days Days9594 100.6%  
Debtors Days Days10874 146.4%  
Net fixed assets Rs m213,1781,791 11,903.4%   
Share capital Rs m2,399534 449.2%   
"Free" reserves Rs m378,60610,324 3,667.4%   
Net worth Rs m381,00610,858 3,509.1%   
Long term debt Rs m17,72141 43,011.9%   
Total assets Rs m643,02811,591 5,547.9%  
Interest coverage x9.6260.9 3.7%   
Debt to equity ratio x00 1,225.7%  
Sales to assets ratio x0.40.1 380.4%   
Return on assets %4.914.1 34.8%  
Return on equity %6.915.0 46.1%  
Return on capital %10.015.2 66.0%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m40,81619 210,393.8%   
Fx outflow Rs m30,143264 11,425.7%   
Net fx Rs m10,673-244 -4,366.7%   
CASH FLOW
From Operations Rs m39,072236 16,569.8%  
From Investments Rs m-33,708-224 15,048.3%  
From Financial Activity Rs m-15,393-27 57,866.9%  
Net Cashflow Rs m-7,359-15 49,723.6%  

Share Holding

Indian Promoters % 63.7 64.0 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 0.2 2,565.0%  
FIIs % 23.0 9.7 237.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 26.1 31.8%  
Shareholders   133,026 54,701 243.2%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   CIPLA  PFIZER  NATCO PHARMA  SHASUN PHARMA  SANOFI INDIA  

Compare SUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Energy and Automobiles Stocks Drag(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.9% while the Hang Seng is up 0.2%.

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jul 23, 2019 10:49 AM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS